MedTrace Logo

Postprandial Regulation of Bone Perfusion in Healthy Individuals

NCT07679516 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2026-07-09

No results posted yet for this study

Summary

The goal of this clinical trial is to learn whether certain natural hormones - Glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-2, (GLP-2), and amylin - affect blood flow to the bones.

Conditions

  • Healthy Adult Participants
  • Bone Physiology
  • Bone Blood Flow Regulation
  • Peptide Hormones

Interventions

OTHER

isotonic saline infusion

Placebo infusion for comparison of active hormone

OTHER

Infusion of GIP(1-42)

Study tool

OTHER

Infusion of GLP-2(1-33)

Study tool

OTHER

Infusion of pramlintide

Study tool

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    collaborator OTHER

  • University of Copenhagen

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
25 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-07-19
Primary Completion
2028-05-31
Completion
2028-05-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07679516 on ClinicalTrials.gov